Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03807063
Title Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Washington
Indications

chronic myelomonocytic leukemia

myelodysplastic/myeloproliferative neoplasm

myelodysplastic syndrome

chronic myeloid leukemia

acute myeloid leukemia

chronic lymphocytic leukemia

acute lymphoblastic leukemia

myeloproliferative neoplasm

Therapies

Rimiducid

BPX-501

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.